MyoKi
Products
Information
MyoKi: Muscle Health Redefined in the GLP-1 Era As GLP-1 agonists gain global popularity for weight loss and metabolic control, concerns over unintended muscle loss—particularly in older adults and non-obese individuals—are growing. MyoKi offers a novel, peptide-based solution that counteracts this effect by selectively inhibiting myostatin, a key regulator of muscle atrophy.
All Categories
Peptides
Main Categories
Innovative APIs
